Origins of Venomtech

Venomtech was founded in March 2010 by Steven Trim to help solve one of the problems he had often encountered as a pharmaceutical scientist - finding adequate new drug leads. Steve's passion and drive for drug discovery is intimately linked to his desire to advance human healthcare and to his personal experience of the challenges in drug discovery. During his tenure at Pfizer, he worked on several drug discovery programmes where the team struggled considerably to obtain good candidate molecules or adequate tools to rapidly advance its projects.

Management Team

Founder/ CSO/ General Manager - Steven Trim

Steven Trim BSc, CBiol, MRSB spent a decade working as a molecular biologist in drug discovery at Pfizer (Sandwich, Kent). He has worked extensively on pain therapeutics and developed expertise in tissue repair, gastrointestinal and respiratory fields. Having worked across molecular biology, pharmacology, biochemistry and anatomy, Steve has a deep understanding of drug discovery and the use of venoms and toxins in this area. Drawing on his experience at Pfizer, he founded Venomtech Ltd in 2010 with the goal of solving the problems the industry faces in finding new medicines.

Steve Trim - LinkedIn

Interim Chairman - Professor Karol Sikora

Professor Karol Sikora MA, MBBChir, PhD, MD, FRCR, FRCP, FRCPE, FFPM is a Consultant Oncologist at Hammersmith Hospital, London. He launched CancerPartnersUK, Britain's largest independent network of innovative cancer treatment centres. He was Chief of the World Health Organisation's Cancer Programme between 1997 and 1999 and has been an adviser to the UN's International Atomic Energy Agency. Karol provides invaluable expertise in oncology and therapeutics.



Commercial Director - Paul Grant​

Doctor Paul Grant MSc. PhD has 10 years experience in academic research, including Kings College London and St. Georges Hospital, London,  and 12 years experience in drug discovery business development. In this time, he has developed deep industry knowledge, contacts and scientific credibility. Paul has worked with major pharmaceutical, biotechnology, academic, CRO and diagnostic companies across Europe, USA and Asia.


Paul Grant - LinkedIn


Available products for cosmetics and drug discovery

Anti-inflammatory cosmetic skin


Cosmetic peptides to soothe skin and reduce inflammation

Antipollution skin toxins


Cosmetic peptides to protect skin from toxins and pollutants

Venom cosmetic drug discovery


Our bespoke cosmetic peptide design service

Venom target based drug discovery


Target-based venom arrays for hard-to-hit drug targets

Therapeutic venom drug discovery

Therapeutic areas 

Venom arrays for antimicrobial, pain, cancer research, etc.

Venom drug discovery research

Custom Arrays 

Venom arrays designed by us for your target or research area

Resources: Supporting material to aid your research

Science Exchange

Do business via the world's leading and most secure R&D outsourcing platform

Papers and Posters venom

Papers & Posters

Helpful publications from our team, our partners and key industry sources

News and Events venom

News & Media

Up-to-date events and news items about the species, the science and our team

People and partners venom


Find  answers to your most frequently asked questions regarding our products